O-sulfate groups of heparin are critical for inhibition of ecotropic murine leukemia virus infection by heparin

Virology

Volumn 424, Issue 1, 2012, Pages 56-66

  Seki, Yohei ^a   Mizukura, Misaho ^a   Ichimiya, Tomomi ^a   Suda, Yasuo ^b   Nishihara, Shoko ^a   Masuda, Michiaki ^c   Takase Yoden, Sayaka ^a  

^a SOKA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Env protein; Heparin; Murine leukemia virus; Sulfation; Surface plasmon resonance

Indexed keywords

HEPARIN; N SULFATE; O SULFATE; SULFATE; SULFUR ACID DERIVATIVE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

A8 MURINE LEUKEMIA VIRUS; ARTICLE; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; ECOTROPIC VIRUS; FRIEND LEUKEMIA VIRUS; HUMAN; HUMAN CELL; MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PVC 211 MURINE LEUKEMIA VIRUS; STRAIN DIFFERENCE; SULFATION; SURFACE PLASMON RESONANCE; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS STRAIN;

ANIMALS; DOWN-REGULATION; HEPARIN; LEUKEMIA VIRUS, MURINE; MICE; MOLECULAR STRUCTURE; NIH 3T3 CELLS; RETROVIRIDAE INFECTIONS; RODENT DISEASES; VIRAL ENVELOPE PROTEINS;

MURINE LEUKEMIA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 84856213968     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.11.030     Document Type: Article

References (43)

1. Albritton L.M., Tseng L., Scadden D., Cunningham J.M. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989, 57:659-666.
2. Batra R.K., Olsen J.C., Hoganson D.K., Caterson B., Boucher R.C. Retroviral gene transfer is inhibited by chondroitin sulfate proteoglycans/glycosaminoglycans in malignant pleural effusions. J. Biol. Chem. 1997, 272:11736-11743.
3. Capila I., Linhardt R.J. Heparin-protein interactions. Angew. Chem. 2002, 41:391-412.
4. Cardin A.D., Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32.
5. Copeland R., Balasubramaniam A., Tiwari V., Zhang F., Bridges A., Linhardt R.J., Shukla D., Liu J. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 2008, 47:5774-5783.
6. Crublet E., Andrieu J.P., Vives R.R., Lortat-Jacob H. The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. J. Biol. Chem. 2008, 283:15193-15200.
7. Czub M., Czub S., McAtee F.J., Portis J.L. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J. Virol. 1991, 65:2539-2544.
8. Davis H.E., Morgan J.R., Yarmush M.L. Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes. Biophys. Chem. 2002, 97:159-172.
9. Davis H.E., Rosinski M., Morgan J.R., Yarmush M.L. Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys. J. 2004, 86:1234-1242.
10. Fass D., Davey R.A., Hamson C.A., Kim P.S., Cunningham J.M., Berger J.M. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 1997, 277:1662-1666.
11. Guibinga G.H., Miyanohara A., Esko J.D., Friedmann T. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol. Ther. 2002, 5:538-546.
12. Hallak L.K., Spillmann D., Collins P.L., Peeples M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 2000, 74:10508-10513.
13. Jinno-Oue A., Oue M., Ruscetti S.K. A unique heparin-binding domain in the envelope protein of the neuropathogenic PVC-211 murine leukemia virus may contribute to its brain capillary endothelial cell tropism. J. Virol. 2001, 75:12439-12445.
14. Kai K., Furuta T. Isolation of paralysis-inducing murine leukemia viruses from Friend virus passaged in rats. J. Virol. 1984, 50:970-973.
15. Kim J.W., Closs E.I., Albritton L.M., Cunningham J.M. Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 1991, 352:725-728.
16. Krusat T., Streckert H.J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch. Virol. 1997, 142:1247-1254.
17. Landazuri N., Le Doux J.M. Complexation of retroviruses with charged polymers enhances gene transfer by increasing the rate that viruses are delivered to cells. J. Gene Med. 2004, 6:1304-1319.
18. Le Doux J.M., Morgan J.R., Snow R.G., Yarmush M.L. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J. Virol. 1996, 70:6468-6473.
19. Le Doux J.M., Morgan J.R., Yarmush M.L. Differential inhibition of retrovirus transduction by proteoglycans and free glycosaminoglycans. Biotechnol. Prog. 1999, 15:397-406.
20. Masuda M., Remington M.P., Hoffman P.M., Ruscetti S.K. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211. J. Virol. 1992, 66:2798-2806.
21. Masuda M., Hanson C.A., Dugger N.V., Robbins D.S., Wilt S.G., Ruscetti S.K., Hoffman P.M. Capillary endothelial cell tropism of PVC-211 murine leukemia virus and its application for gene transduction. J. Virol. 1997, 71:6168-6173.
22. Mondor I., Ugolini S., Sattentau Q.J. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 1998, 72:3623-3634.
23. Neyts J., Snoeck R., Schols D., Balzarini J., Esko J.D., Van Schepdael A., De Clercq E. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 1992, 189:48-58.
24. Oliff A.I., Hager G.L., Chang E.H., Scolnick E.M., Chan H.W., Lowy D.R. Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper-independent type C virus. J. Virol. 1980, 33:475-486.
25. Patel M., Yanagishita M., Roderiquez G., Bou-Habib D.C., Oravecz T., Hascall V.C., Norcross M.A. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 1993, 9:167-174.
26. Pizzato M., Marlow S.A., Blair E.D., Takeuchi Y. Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J. Virol. 1999, 73:8599-8611.
27. Rider C.C., Coombe D.R., Harrop H.A., Hounsell E.F., Bauer C., Feeney J., Mulloy B., Mahmood N., Hay A., Parish C.R. Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry 1994, 33:6974-6980.
28. Robert-Guroff M., Schrecker A.W., Brinkman B.J., Gallo R.C. DNA polymerase gamma of human lymphoblasts. Biochemistry 1977, 16:2866-2873.
29. Sato M., Ito Y., Arima N., Baba M., Sobel M., Wakao M., Suda Y. High-sensitivity analysis of naturally occurring sugar chains, using a novel fluorescent linker molecule. J. Biochem. 2009, 146:33-41.
30. Secchiero P., Sun D., De Vico A.L., Crowley R.W., Reitz M.S., Zauli G., Lusso P., Gallo R.C. Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans. J. Virol. 1997, 71:4571-4580.
31. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99:13-22.
32. Suda Y., Arano A., Fukui Y., Koshida S., Wakao M., Nishimura T., Kusumoto S., Sobel M. Immobilization and clustering of structurally defined oligosaccharides for sugar chips: an improved method for surface plasmon resonance analysis of protein-carbohydrate interactions. Bioconjug. Chem. 2006, 17:1125-1135.
33. Takada A., Robison C., Goto H., Sanchez A., Murti K.G., Whitt M.A., Kawaoka Y. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14764-14769.
34. Takase-Yoden S., Watanabe R. Unique sequence and lesional tropism of a new variant of neuropathogenic Friend murine leukemia virus. Virology 1997, 233:411-422.
35. Tamura T.-A., Takano T. A new, rapid procedure for the concentration of C-type viruses from large quantities of culture media: ultrafiltration by diaflo membrane and purification by ficoll gradient centrifugation. J. Gen. Virol. 1978, 41:135-141.
36. Trybala E., Bergström T., Spillmann D., Svennerholm B., Olofsson S., Flynn S.J., Ryan P. Mode of interaction between pseudorabies virus and heparan sulfate/heparin. Virology 1996, 218:35-42.
37. Trybala E., Liljeqvist J.A., Svennerholm B., Bergström T. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J. Virol. 2000, 74:9106-9114.
38. Walker S.J., Pizzato M., Takeuchi Y., Devereux S. Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. J. Virol. 2002, 76:6909-6918.
39. Wang H., Kavanaugh M.P., North R.A., Kabat D. Cell-surface receptor for ecotropic murine retroviruses is a basic amino-acid transporter. Nature 1991, 352:729-731.
40. Watanabe R., Takase-Yoden S. Gene expression of neurotropic retrovirus in the CNS. Prog. Brain Res. 1995, 105:255-262.
41. WuDunn D., Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 1989, 63:52-58.
42. Xia G., Chen J., Tiwari V., Ju W., Li J.P., Malmstrom A., Shukla D., Liu J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 2002, 277:37912-37919.
43. Ye S., Luo Y., Lu W., Jones R.B., Linhardt R.J., Capila I., Toida T., Kan M., Pelletier H., McKeehan W.L. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry 2001, 40:14429-14439.